Comparative evaluation of microplate enzyme-linked immunosorbent assay versus plaque reduction assay for antiviral susceptibility testing of herpes simplex virus isolates

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 1017-1019

  Safrin, Sharon ^a,b   Palacios, Emil ^a,b   Leahy, Bradley J ^c  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FOSCARNET;

AUTORADIOGRAPHY; DRUG RESPONSE; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES SIMPLEX VIRUS; NOTE; PREDICTION; PRIORITY JOURNAL; REPRODUCIBILITY; VERO CELL; VIRUS CULTURE; VIRUS ISOLATION;

EID: 0029995242     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.1017     Document Type: Note

References (10)

1. Leahy, B. J., K. J. Christiansen, and G. Shellam. 1994 Standardisation of a microplate in situ ELISA (MISE-test) for the susceptibility testing of herpes simplex virus to acyclovir. J. Virol. Methods 48:93-108.
2. Martin, J. L., M. N. Ellis, P. M. Keller, K. K. Biron, S. N. Lehrman, D. W. Barry, and P. A. Furman. 1985. Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinasealtered mutants of herpes simplex virus in clinical isolates. Antimicrob. Agents Chemother. 28:181-187.
3. McLaren, C., M. N. Ellis, and G. A. Hunter. 1983. A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents. Antiviral Res. 3:223-234.
4. Parris, D. S., J. E. Harrington. 1982. Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates. Antimicrob. Agents Chemother. 22:71-77.
5. Safrin, S., T. Elbeik, L. Phan, D. Robinson, J. Rush, A. Elbaggari, and J. Mills. 1994. The correlation of response to acyclovir and foscarnet therapy with in vitro susceptibility result in isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 38:1246-1250.
6. Safrin, S., S. Kemmerly, B. Plotkin, T. Smith, N. Weissbach, D. De Veranez, L. D. Phan, and D. Colin. 1994. Foscarnet resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. J. Infect. Dis. 169:193-196.
7. Safrin, S., L. Phan, and T. Elbeik. 1995. A comparative evaluation of three methods of antiviral susceptibility testing of clinical herpes simplex virus isolates. Clin. Diagn Virol. 4:81-91.
8. Swierkosz, E. M., D. R. Scholl, J. L. Brown, J. D. Jollick, and C. A. Gleaves. 1987. Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus. Antimicrob. Agents Chemother. 31:1465-1469
9. Tebas, P., E. C. Stabell, and P. D. Olivo. 1995. Antiviral susceptibility testing with a cell line which expresses β-galactosidase after infection with herpes simplex virus. Antimicrob. Agents Chemother. 39:1287-1291.
10. Zar, J. H. 1984. Biostatistical analysis, p. 150-161. Prentice-Hall, Inc , Englewood Cliffs, N.J.